HMGCR and dermatomyositis: However, no significant differences were observed between the serum levels of miR-23b-3p, miR-146a-5p, and miR-146b-5p in DM patients with MSAs (anti-ARS, anti-SAE, anti-TIF1-γ, anti-Mi-2, anti-SRP, and HMGCR autoantibodies) and those patients without MSAs (data not shown).